Category: Judicial

PhRMA to Federal Appeals Court: Arkansas Enforcing 340B Contract Pharmacy Law; Seventh Drugmaker Sues Over IRA

September 6, 2023 William Newton, Associate Editor/Senior Writer Views

PhRMA filed a citation to notify the U.S. Eighth Circuit Court of Appeals in St. Louis that Arkansas is enforcing its 340B contract pharmacy law.

The drug industry group challenging the legality of Arkansas’ 340B contract pharmacy law, notified a federal appeals court that the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Little Chance Congress Clears 340B Overhaul in 2023—Unless Courts Act, Say Lobbyists

August 31, 2023 Rich Daly, Editor in Chief Views

Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program.

Congress is unlikely to clear any major reform of the 340B in the remaining months of 2023, unless spurred by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Boehringer Ingelheim Sues to Block Medicare Price Negotiations

August 31, 2023 William Newton, Associate Editor/Senior Writer Views

Boehringer Ingelheim sued the federal government to block Medicare price negotiations shortly before its diabetes drug was picked for negotiations.

Drug maker Boehringer Ingelheim (BI) sued the federal government to block Medicare price negotiations shortly before the Department of Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Judge Accepts Drug Company Filings in 340B Patient Definition Case

August 29, 2023 Tom Mirga, Editor at Large Views

Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.

A federal district judge has allowed five major drugmakers to file friend-of-the-court briefs in a lawsuit over patient eligibility to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AstraZeneca Sues to Block Medicare Price Negotiations Over ‘Unintended Consequences’ to Orphan Drug Development

August 29, 2023 William Newton, Associate Editor/Senior Writer Views

AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year but allow 340B covered entities to replenish their supply with an equivalent dose in blister pack package form.

Drugmaker AstraZeneca sued the federal government to block Medicare drug price negotiations on Friday, just days before the government announced [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Center Asks Court to Reject Drug Maker Briefs in Challenge to 340B Patient Definition

August 24, 2023 William Newton, Associate Editor/Senior Writer Views

Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.

A health center challenging the government’s 340B program patient definition in a federal district court recently asked a federal judge [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

From the Publisher & CEO: The Big Question on the Minds of Every 340B Stakeholder

August 24, 2023 Rich Daly, Editor in Chief Views

340B stakeholders are anticipating two major contract pharmacy judicial rulings, including one from the Court of Appeals for the District of Columbia.

Amid nationwide uncertainty over both the legality of the scope of the 340B contract pharmacy program and the legality of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Appeals Court Schedules Arguments in Challenge to Arkansas Contract Pharmacy Law

August 22, 2023 William Newton, Associate Editor/Senior Writer Views

Two states have laws protecting 340B contract pharmacy arrangements and two others have passed 340B reporting requirements.

A federal appeals court has scheduled oral arguments for September in a case challenging Arkansas’ protections for 340B providers’ contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HHS Asks Court to Deny Injunction Against Medicare Drug Price Negotiations

August 17, 2023 Tom Mirga, Editor at Large Views

HHS asked the U.S. District Court in Dayton, Ohio to deny a preliminary injunction that would prevent Medicare drug price negotiations.

The U.S. Department of Health and Human Services (HHS) asked a federal court to deny a preliminary injunction sought by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Major Drug Company Sues Louisiana Over 340B Contract Pharmacy Law

August 15, 2023 William Newton, Associate Editor/Senior Writer Views

Drug manufacturer AstraZeneca, one of the first companies to place restrictions on 340B discounts in the contract pharmacy setting, has [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live